In the News The Deal

Abbott Seeks April Trial for Bid to Escape Alere Merger

"Abbott Laboratories (ABT) is asking Delaware Vice Chancellor Sam Glasscock III for an April trial date in a lawsuit where the medical device company is seeking to walk from its $7.9 billion agreement to buy Alere Inc. (ALR)

James Hurst, Andrew Kassof and Brenton Rogers of Kirkland & Ellis LLP in Chicago are advising Abbott in the Delaware litigation along with John O'Quinn in the firm's Washington office.Kirkland's Daniel Wolf, David Feirstein, Laura Sullivan and John Kupiec were M&A counsel."

To read the full text of this article (subscription required) please click here.

This article appeared in its entirety in the December 13, 2016 edition of The Deal.